Autonomous robotic ultrasound system evaluated for thyroid nodule assessment
Autonomous ultrasound robots moving into prospective multicenter trials signal that AI-guided screening is graduating from lab demos to clinical evidence. Clinicians and medtech teams tracking diagnostic imaging automation can use this study as a reference point for regulatory-grade validation. Readers can compare its trial design with other autonomous imaging systems heading toward approval.